BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3038364)

  • 1. Beneficial effects of a leukotriene antagonist on endotoxin-induced acute hemodynamic alterations.
    Etemadi AR; Tempel GE; Farah BA; Wise WC; Halushka PV; Cook JA
    Circ Shock; 1987; 22(1):55-63. PubMed ID: 3038364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of a selective leukotriene antagonist in endotoxemia in the rat.
    Cook JA; Wise WC; Halushka PV
    J Pharmacol Exp Ther; 1985 Nov; 235(2):470-4. PubMed ID: 2997435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of leukotriene receptor antagonists on vascular permeability during endotoxic shock.
    Cook JA; Li EJ; Spicer KM; Wise WC; Halushka PV
    Circ Shock; 1990 Nov; 32(3):209-18. PubMed ID: 2175680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primate myocardial and systemic hemodynamic responses to leukotriene D4: antagonism by LY171883.
    Hahn RA; MacDonald BR
    J Pharmacol Exp Ther; 1987 Jul; 242(1):62-9. PubMed ID: 3612538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance of essential fatty acid-deficient rats to endotoxin-induced increases in vascular permeability.
    Li EJ; Cook JA; Spicer KM; Wise WC; Rokach J; Halushka PV
    Circ Shock; 1990 Jun; 31(2):159-70. PubMed ID: 2188748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the leukotriene receptor antagonist LY-171883 on endotoxemia in awake sheep.
    Krausz MM; Dahan JB; Gross D
    Circ Shock; 1988 Dec; 26(4):431-41. PubMed ID: 2850874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukotriene D4 and hypoxia: differential effects on the pulmonary and systemic circulations in newborn piglets.
    Bradley LM; Feuerstein G; Goldstein RE; Czaja JF
    Eicosanoids; 1989; 2(1):15-20. PubMed ID: 2633795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of LY203647 on cardiovascular leukotriene D4 receptors and myocardial reperfusion injury.
    Hahn RA; MacDonald BR; Morgan E; Potts BD; Parli CJ; Rinkema LE; Whitesitt CA; Marshall WS
    J Pharmacol Exp Ther; 1992 Mar; 260(3):979-89. PubMed ID: 1312172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oleic acid-induced pulmonary injury in rats: potential role of sulfidopeptide leukotrienes.
    Ball HA; Cook JA; Spicer KM; Hsu CY; Halushka PV
    Circ Shock; 1988 Sep; 26(1):59-70. PubMed ID: 2847882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of dual cyclooxygense and leukotriene blockade with ibuprofen and LY203647 during canine endotoxic shock.
    Passmore JC; Jimenez AE
    Circ Shock; 1993 Jan; 39(1):21-8. PubMed ID: 8481974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the LTD4 receptor antagonist LY203647 on endotoxic shock sequelae in the rat.
    Li EJ; Cook JA; Ashton S; Wise WC; Halushka PV
    Eur J Pharmacol; 1991 Jun; 199(2):221-5. PubMed ID: 1954979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic and renal advantages of dual cyclooxygenase and leukotriene blockade during canine endotoxic shock.
    Young JS; Passmore JC
    Circ Shock; 1990 Nov; 32(3):243-55. PubMed ID: 2175681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of an orally active leukotriene D4/E4 antagonist, LY171883, on antigen-induced airway responses in allergic sheep.
    Abraham WM; Wanner A; Stevenson JS; Chapman GA
    Prostaglandins; 1986 Mar; 31(3):457-67. PubMed ID: 3754973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effects of LY203647, a novel leukotriene C4/D4 antagonist, on pulmonary function and mesenteric perfusion in a porcine model of endotoxic shock and ARDS.
    Cohn SM; Kruithoff KL; Rothschild HR; Wang HL; Antonsson JB; Fink MP
    Circ Shock; 1991 Jan; 33(1):7-16. PubMed ID: 2009603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effects of a new LTD4 antagonist (LY-171883) in traumatic shock.
    Hock CE; Lefer AM
    Circ Shock; 1985; 17(4):263-72. PubMed ID: 3841503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-related antagonism of leukotriene D4-induced bronchoconstriction by p.o. administration of LY-171883 in nonasthmatic subjects.
    Phillips GD; Rafferty P; Robinson C; Holgate ST
    J Pharmacol Exp Ther; 1988 Aug; 246(2):732-8. PubMed ID: 3404455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentration-dependent, stereoselective inhibition of the endotoxin-induced hemoconcentration in conscious rats with the peptidoleukotriene receptor antagonist SK & F 104353.
    Smith EF; Kinter LB; Jugus M; Eckardt RD; Newton JF
    Eicosanoids; 1989; 2(2):101-7. PubMed ID: 2560662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The improvement in endotoxin-induced redistribution of organ blood flow by inhibition of thromboxane and prostaglandin synthesis.
    Tempel GE; Cook JA; Wise WC; Halushka PV
    Adv Shock Res; 1982; 7():209-18. PubMed ID: 6753535
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of a platelet-activating factor antagonist, CV-3988, on different shock models in the rat.
    Toth PD; Mikulaschek AW
    Circ Shock; 1986; 20(3):193-203. PubMed ID: 3802423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endotoxemia in rats--influence of lipoxygenase blocker versus leukotriene receptor antagonist (BW755C vs LY171883).
    Bahrami S; Paul E; Redl H; Schlag G; Mihm F
    Prog Clin Biol Res; 1988; 272():283-92. PubMed ID: 2839854
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.